Study finds GLP-1 medicines cut fat while preserving muscle function
View as a Web Page
News Medical
 
  Women's Health Women's Health logo  
  The latest women's health news from News Medical  
 Menopause may raise women’s Alzheimer risk earlier than doctors once thoughtMenopause may raise women’s Alzheimer risk earlier than doctors once thought
 
This review argues that women’s higher Alzheimer disease risk may be shaped in part by midlife neuroendocrine aging, especially the menopause transition, rather than by longevity alone. It highlights early menopause, bilateral oophorectomy, vasomotor symptoms, and midlife cognitive changes as underinvestigated but potentially important risk markers, while calling for sex-specific, biomarker-driven prevention strategies.
 
 
 Study finds GLP-1 medicines cut fat while preserving muscle functionStudy finds GLP-1 medicines cut fat while preserving muscle function
 
Researchers found that GLP-1 medicines caused weight loss mainly through fat reduction, with only modest decreases in absolute muscle mass and no disproportionate loss of muscle function. In mice, physical performance improved, while in a small 12-week human pilot trial, strength was preserved despite reduced thigh muscle size.
 
   Yogurt, cheese, and chocolate consumption is tied to reduced mortality risk, researchers reportYogurt, cheese, and chocolate consumption is tied to reduced mortality risk, researchers report
 
A large meta-analysis of 50 cohort studies involving over three million adults found that higher consumption of certain fermented foods is associated with lower risks of all-cause and cardiovascular mortality. Fermented milk products also showed inverse associations with cancer mortality, while other foods like miso and bread showed no consistent effects.
 
   A healthier thymus predicts longer life and lower cancer and heart disease risk in adultsA healthier thymus predicts longer life and lower cancer and heart disease risk in adults
 
Imaging-based analysis of over 27,000 adults shows that better thymic health is strongly associated with lower all-cause mortality, reduced lung cancer risk, and improved cardiovascular outcomes. The findings suggest the thymus remains biologically relevant in adulthood, linking immune aging, inflammation, and chronic disease risk, although causality cannot be established.
 
   How one antibiotic dose can reshape your gut microbiome for yearsHow one antibiotic dose can reshape your gut microbiome for years
 
Long-term registry-linked analysis of nearly 15,000 adults shows that antibiotic use is associated with persistent changes in gut microbiome diversity and composition for up to 4–8 years. These effects vary by antibiotic class, with clindamycin, fluoroquinolones, and flucloxacillin showing the strongest and most sustained associations.
 
 U.S. study links ultra-processed foods to lower odds of fertility
 
U.S. study links ultra-processed foods to lower odds of fertilityA cross-sectional NHANES study of 2,582 U.S. women found that higher ultra-processed food intake was associated with lower odds of being classified as fertile based on self-reported infertility history. Greater Mediterranean diet adherence was linked to higher odds of fertility in adjusted models, but that association was no longer significant after accounting for obesity.
 
 
 Higher meat intake may slow cognitive decline in older adults with APOE ε4
 
Higher meat intake may slow cognitive decline in older adults with APOE ε4In older Swedish adults, higher meat intake was associated with slower cognitive decline and lower dementia risk among people carrying APOE ε3/ε4 or ε4/ε4, but not among other genotype groups. A higher processed-to-total meat ratio was linked to worse dementia outcomes, while unprocessed red meat and poultry showed no substantial difference.
 
 
 Study finds a clear link between ultraprocessed food and heart disease risk
 
Study finds a clear link between ultraprocessed food and heart disease riskA prospective analysis of 6,531 adults in the multiethnic MESA cohort found that higher ultraprocessed food intake was associated with a graded increase in incident ASCVD risk, with each additional daily serving linked to about a 5% higher risk. The association was stronger in Black participants, while no significant interaction was seen by sex or income.
 
 
 GLP-1 drugs cut heart and kidney risks in type 1 diabetes study
 
GLP-1 drugs cut heart and kidney risks in type 1 diabetes studyIn a large target trial emulation of 174,678 people with type 1 diabetes, GLP-1 receptor agonist initiation was associated with lower risks of major cardiovascular events and end-stage kidney disease over five years. The study also found no increased risk of hospitalization for diabetic ketoacidosis or severe hypoglycemia, supporting further randomized trials of GLP-1RAs as adjunctive therapy in type 1 diabetes.
 
 
 Why are men missing cancer tests despite higher positive rates?
 
Why are men missing cancer tests despite higher positive rates?A study highlights a gap in cancer prevention, showing men undergo genetic testing less often yet are more likely to carry high-risk cancer variants.
 
 
 Cancer cells rely on glutathione as fuel for growth
 
Cancer cells rely on glutathione as fuel for growthResearchers discovered an antioxidant, glutathione, that cancer cells appear to be "addicted to" as fuel, opening new pathways for investigation and a potential drug that can restrict the way tumors use this nutrient.
 
 
 Gut-derived blood markers may help predict who develops coronary heart disease
 
Gut-derived blood markers may help predict who develops coronary heart diseaseResearchers used five prospective cohorts from the US and China to identify circulating gut microbiota-related metabolites linked to future coronary heart disease, then tested the findings through discovery, in silico validation, and targeted quantitative validation. The study ultimately highlighted nine metabolites associated with incident CHD, supporting a potential role for microbial metabolism in heart disease risk while not proving causation
 
 
 How long should you take GLP-1 drugs? Study links longer use to lower heart risk
 
How long should you take GLP-1 drugs? Study links longer use to lower heart riskContinuous use of GLP-1 receptor agonists in adults with type 2 diabetes was associated with a lower risk of major cardiovascular events compared with sulfonylureas, with benefits increasing over time. Discontinuation or interruption was associated with a progressive loss of this protective effect, with risks approaching those of comparator therapy.
 
 
 Blood-based test helps personalize breast cancer care for older patients
 
Blood-based test helps personalize breast cancer care for older patientsFor women age 70 and over with a common form of breast cancer, determining "the right size" of treatment can be challenging, in part because clinicians have limited tools to guide individualized treatment decisions.
 
 
 Young women face rising mortality rates from high blood pressure
 
Young women face rising mortality rates from high blood pressureNearly 1 in 2 Americans has high blood pressure—sometimes called the "silent killer" because it harms the heart and blood vessels—but many people don't know they have it.
 
 
 Combination therapy shows promise for leptomeningeal metastasis in breast cancer
 
Combination therapy shows promise for leptomeningeal metastasis in breast cancerPatients with leptomeningeal metastasis (LM) have historically had few treatment options. Now, researchers from The University of Texas MD Anderson Cancer Center have found a combination of targeted therapies, tucatinib and trastuzumab, plus the chemotherapy drug, capecitabine, may improve symptoms and extend survival in some breast cancer patients with LM.
 
 
 Study: Women survive cancer more but face higher treatment toxicity
 
Women are more likely to survive cancer than men but face a higher risk of serious and adverse side effects from treatment, according to a landmark international study from Adelaide University.
 
 
 Weight-loss drugs linked to preterm birth risk in women with pre-existing diabetes
 
Weight loss drugs have been linked to an increased risk of premature births among women who took them inadvertently just before or during early pregnancy to treat pre-existing diabetes.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2026